In order to further explore the role of FASTKD2, we evaluated the value of high expression of FASTKD2 as a predictor of lung adenocarcinoma for the first time, with a sensitivity of 0.949, which is particularly conducive to the screening of lung adenocarcinoma. Here, FASTKD2 is linked to lung adenocarcinoma.